NCT00251199已完成1 期
A Phase 1b Viral Kinetic Study of VX-950 and Peginterferon in Hepatitis C
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 20
- 试验地点
- 2
- 主要终点
- Viral kinetics
研究概览
简要总结
VX-950 is an investigational drug , which is being tested in combination with a known treatment for hepatitis C, peginterferon.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 盲法
- Double
入排标准
- 年龄范围
- 18 Years 至 60 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •infected with Hepatitis C virus
排除标准
- •contraindications to peginterferon therapy
结局指标
主要结局
Viral kinetics
次要结局
- Assess the safety of VX-950 in combination with peginterferon
研究者
研究点 (2)
Loading locations...
相似试验
已完成
1 期
A Study to Evaluate the Relative Bioavailability and Food Effect of a New Tablet Formulation of VX-993PainNCT06508762Vertex Pharmaceuticals Incorporated24
进行中（未招募）
2 期
The Combination of Venetoclax and Obinutuzumab in People With Chronic Lymphocytic Leukemia (CLL)Chronic Lymphocytic Leukemia (CLL)NCT04447768Memorial Sloan Kettering Cancer Center100
终止
1 期
A Study to Assess the Pharmacokinetics, Safety, and Tolerability of Multiple Doses of Orally Administered JNJ-53718678 in Infants Hospitalized With Respiratory Syncytial Virus (RSV) InfectionVirus DiseasesRespiratory Syncytial Virus InfectionsNCT02593851Janssen Sciences Ireland UC45
已完成
1 期
Evaluating the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of the Monoclonal Antibody PGT121.414.LS Administered Alone and in Combination With VRC07-523LS Via Intravenous or Subcutaneous Infusions in Healthy, HIV-uninfected Adult ParticipantsHIV InfectionsNCT04212091National Institute of Allergy and Infectious Diseases (NIAID)33
招募中
2 期
Clinical Study Protocol of Venetoclax Combined With Azacitidine and Harringtonine in the Treatment of sAMLSecondary Acute Myeloid LeukemiaNCT05513131The First Affiliated Hospital with Nanjing Medical University30